ArticleAnnals of translational medicine2022

FOLFOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer patients with unresectable liver metastases.

Carlotta Antoniotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.